Cargando…

Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G

This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soo Young, Han, Seung Beom, Bae, E Young, Kim, Jong-Hyun, Kang, Jin Han, Park, Yeon-Joon, Ma, Sang Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024945/
https://www.ncbi.nlm.nih.gov/pubmed/24851020
http://dx.doi.org/10.3346/jkms.2014.29.5.652
_version_ 1782316702317412352
author Lee, Soo Young
Han, Seung Beom
Bae, E Young
Kim, Jong-Hyun
Kang, Jin Han
Park, Yeon-Joon
Ma, Sang Hyuk
author_facet Lee, Soo Young
Han, Seung Beom
Bae, E Young
Kim, Jong-Hyun
Kang, Jin Han
Park, Yeon-Joon
Ma, Sang Hyuk
author_sort Lee, Soo Young
collection PubMed
description This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and anti-pertussis toxin (PT) IgG titers were measured using a commercial ELISA kit. We compared the mean anti-PT IgG titers and seroprevalence of pertussis of the six age groups: 11-20, 21-30, 31-40, 41-50, 51-60, and ≥ 61 yr. A total of 1,192 subjects were enrolled. The mean anti-PT IgG titer and pertussis seroprevalence were 35.53 ± 62.91 EU/mL and 41.4%, respectively. The mean anti-PT IgG titers and seroprevalence were not significantly different between the age groups. However, the seroprevalence in individuals 51 yr of age or older was significantly higher than in individuals younger than 51 yr (46.5% vs 39.1%, P = 0.017). Based on these results, a new pertussis prevention strategy is necessary for older adults. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-4024945
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-40249452014-05-21 Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G Lee, Soo Young Han, Seung Beom Bae, E Young Kim, Jong-Hyun Kang, Jin Han Park, Yeon-Joon Ma, Sang Hyuk J Korean Med Sci Original Article This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and anti-pertussis toxin (PT) IgG titers were measured using a commercial ELISA kit. We compared the mean anti-PT IgG titers and seroprevalence of pertussis of the six age groups: 11-20, 21-30, 31-40, 41-50, 51-60, and ≥ 61 yr. A total of 1,192 subjects were enrolled. The mean anti-PT IgG titer and pertussis seroprevalence were 35.53 ± 62.91 EU/mL and 41.4%, respectively. The mean anti-PT IgG titers and seroprevalence were not significantly different between the age groups. However, the seroprevalence in individuals 51 yr of age or older was significantly higher than in individuals younger than 51 yr (46.5% vs 39.1%, P = 0.017). Based on these results, a new pertussis prevention strategy is necessary for older adults. GRAPHICAL ABSTRACT: [Image: see text] The Korean Academy of Medical Sciences 2014-05 2014-04-25 /pmc/articles/PMC4024945/ /pubmed/24851020 http://dx.doi.org/10.3346/jkms.2014.29.5.652 Text en © 2014 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Soo Young
Han, Seung Beom
Bae, E Young
Kim, Jong-Hyun
Kang, Jin Han
Park, Yeon-Joon
Ma, Sang Hyuk
Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title_full Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title_fullStr Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title_full_unstemmed Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title_short Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
title_sort pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin g
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024945/
https://www.ncbi.nlm.nih.gov/pubmed/24851020
http://dx.doi.org/10.3346/jkms.2014.29.5.652
work_keys_str_mv AT leesooyoung pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT hanseungbeom pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT baeeyoung pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT kimjonghyun pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT kangjinhan pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT parkyeonjoon pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling
AT masanghyuk pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling